Macquarie Group’s MediWound MDWD Stock Holding History

Macquarie Group’s Portfolio MDWD Stock Details MDWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-119	Closed	-$2	–	2036
2024 Q1	$2	Buy	+119	New	+$1.63K	﹤0.01%	1854

Other funds holding MDWD

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Macquarie Group's MDWD Position: Q2 2024 in Review

Macquarie Group sold out of MediWound (MDWD) in Q2 2024, closing a stake of 119 shares — an estimated $2 sold.

Macquarie Group first reported a position in MDWD in Q1 2024 and held it in 1 quarter. The position peaked at $2 in Q1 2024. 45 funds tracked by Wall St. Rank hold MDWD as of Q2 2024.

Macquarie Group reported no remaining MediWound position as of Q2 2024 after selling out during the quarter.
Macquarie Group sold 119 MediWound shares in Q2 2024, an estimated $2.
Macquarie Group first reported a position in MediWound in Q1 2024 and held it in 1 quarter.
Macquarie Group's MediWound position peaked at $2 in Q1 2024.
45 funds tracked by Wall St. Rank held MediWound as of Q2 2024.

Based on Macquarie Group's 13F filing for Q2 2024, filed 9 Aug 2024.